AMPD1

gene product
MAD, MADA
Adenosine monophosphate deaminase 1 catalyzes the deamination of AMP to IMP in skeletal muscle and plays an important role in the purine nucleotide cycle. Two other genes have been identified, AMPD2 and AMPD3, for the liver- and erythocyte-specific isoforms, respectively. Deficiency of the muscle-specific enzyme is apparently a common cause of exercise-induced myopathy and probably the most common cause of metabolic myopathy in the human. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene. [provided by RefSeq, Feb 2010]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
246 antibodies from 27 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Novus Biologicals
5 antibodies
Proteintech Group
1 antibody
LifeSpan BioSciences, Inc.
24 antibodies
antibodies-online
100 antibodies
Invitrogen Antibodies
5 antibodies
OriGene
5 antibodies
Acris Antibodies GmbH
5 antibodies
Biorbyt
24 antibodies
Atlas Antibodies
2 antibodies
GeneTex
3 antibodies
NovoPro Bioscience Inc.
3 antibodies
St John's Laboratory
4 antibodies
Aviva Systems Biology
4 antibodies
Abnova Corporation
4 antibodies
ProSci
3 antibodies
Creative Biolabs
3 antibodies
MyBioSource
6 antibodies
Creative Diagnostics
3 antibodies
Sigma-Aldrich
4 antibodies
Leading Biology
3 antibodies
RayBiotech, Inc.
2 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
RabMAbs
1 antibody
Abgent
3 antibodies
Everest Biotech
1 antibody
United States Biological
12 antibodies